Navegar por autor "Afonso Afonso, Francisco Javier"

A Phase II Trial of Erlotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) - a Galician Lung Cancer Group (GGCP) Study

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Barón Duarte, Francisco Javier

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

2013- Afonso Afonso, Francisco Javier; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; [et al.]

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

2013- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; [et al.]

DESCRIPTION OF A SUBPOPULATION OF RENAL PATIENTS WITH LONG-TERM PROGRESSION FREE SURVIVAL (PFS) WITH SUNITINIB: A SOG_GU EXPERIENCE

2012- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Varela Ferreiro, Silvia; Campos Balea, Begoña; Barón Duarte, Francisco Javier [et al.]

Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor

2015- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Lazaro Quintela, Martín; [et al.]

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

2019- AGRASO BUSTO, SARA; VARELA POSE, VANESA; Fernández Nuñez, Natalia; Firvida Perez, Jose Luis; Santome, L.; [et al.]

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study

2012- Afonso Afonso, Francisco Javier; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Fernández Montes, Ana; [et al.]

GAPDH, YWHAZ, and RRN18S as control reference genes for gene expression studies on renal cell carcinoma (RCC) formaldehyde-fixed paraffin-embedded (FFPE) tissue samples

2011- Afonso Afonso, Francisco Javier; Valladares Ayerbes, Manuel; Antón Aparicio, Luis Miguel; Medina Villaamil, Vanessa; Fernández Calvo, Ovidio; [et al.]

GUÍA TERAPÉUTICA EMPÍRICA DA NEUTROPENIA FEBRIL PR-CLN-49/02. Área Sanitaria de Ferrol

2025-03-12- Allegue Rodríguez, Lidia; Fernández Hervás, Hugo; Alonso Girón, María; Saído Toimil, Fátima; Níñez Lorigados, Rubén; [et al.]

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience

2012- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; [et al.]

Paclitaxel and irinotecan in platinum refractory or resistant patients with small cell lung cancer: Experience from the Galician Lung Cancer Group

2013- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Campos Balea, Begoña; [et al.]

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

2020- García González, Jorge José; RUIZ BAÑOBRE, JUAN; Afonso Afonso, Francisco Javier; Amenedo-Gancedo, Margarita; Areses Manrique, María Carmen; [et al.]

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.

2015- Afonso Afonso, Francisco Javier; Anido Herranz, Urbano; Fernández Nuñez, Natalia; García Mata, Jesús; Firvida Perez, Jose Luis; [et al.]

Radium-223 dichloride: A new paradigm in the treatment of prostate cancer

2015- Afonso Afonso, Francisco Javier; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Lazaro Quintela, Martín; Vázquez Estévez, Sergio [et al.]

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile

2014- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Lazaro Quintela, Martín

The functional role of CA9 and glucose transporters (GLUT) in human renal cell carcinoma

2012- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Aparicio Gallego, Guadalupe; Medina Villaamil, Vanessa; Santamarina Cainzos, Isabel; [et al.]

Tumor Inflamatorio Miofibroblastico Exofitico Del Estomago Con Hemoperitoneo Espontaneo. Presentacion atipica de un tumor infrecuente

2013- Afonso Afonso, Francisco Javier; Álvarez Fernández , Juan Carlos; Sardina Ferreiro, Raquel; Used Aznar, Maria del Mar; Del Castillo Fraile, Marcelino [et al.]

Repositorio digital RUNA

Navegar por autor "Afonso Afonso, Francisco Javier"

A Phase II Trial of Erlotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) - a Galician Lung Cancer Group (GGCP) Study ﻿

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study ﻿

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group ﻿

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor ﻿

DESCRIPTION OF A SUBPOPULATION OF RENAL PATIENTS WITH LONG-TERM PROGRESSION FREE SURVIVAL (PFS) WITH SUNITINIB: A SOG_GU EXPERIENCE ﻿

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study ﻿

Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor ﻿

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation ﻿

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study ﻿

GAPDH, YWHAZ, and RRN18S as control reference genes for gene expression studies on renal cell carcinoma (RCC) formaldehyde-fixed paraffin-embedded (FFPE) tissue samples ﻿

GUÍA TERAPÉUTICA EMPÍRICA DA NEUTROPENIA FEBRIL PR-CLN-49/02. Área Sanitaria de Ferrol ﻿

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience ﻿

Paclitaxel and irinotecan in platinum refractory or resistant patients with small cell lung cancer: Experience from the Galician Lung Cancer Group ﻿

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis ﻿

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study. ﻿

Radium-223 dichloride: A new paradigm in the treatment of prostate cancer ﻿

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile ﻿

The functional role of CA9 and glucose transporters (GLUT) in human renal cell carcinoma ﻿

Tumor Inflamatorio Miofibroblastico Exofitico Del Estomago Con Hemoperitoneo Espontaneo. Presentacion atipica de un tumor infrecuente ﻿

A Phase II Trial of Erlotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) - a Galician Lung Cancer Group (GGCP) Study

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

DESCRIPTION OF A SUBPOPULATION OF RENAL PATIENTS WITH LONG-TERM PROGRESSION FREE SURVIVAL (PFS) WITH SUNITINIB: A SOG_GU EXPERIENCE

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study

Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study

GAPDH, YWHAZ, and RRN18S as control reference genes for gene expression studies on renal cell carcinoma (RCC) formaldehyde-fixed paraffin-embedded (FFPE) tissue samples

GUÍA TERAPÉUTICA EMPÍRICA DA NEUTROPENIA FEBRIL PR-CLN-49/02. Área Sanitaria de Ferrol

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience

Paclitaxel and irinotecan in platinum refractory or resistant patients with small cell lung cancer: Experience from the Galician Lung Cancer Group

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.

Radium-223 dichloride: A new paradigm in the treatment of prostate cancer

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile

The functional role of CA9 and glucose transporters (GLUT) in human renal cell carcinoma

Tumor Inflamatorio Miofibroblastico Exofitico Del Estomago Con Hemoperitoneo Espontaneo. Presentacion atipica de un tumor infrecuente